Cargando…
Extractables & Leachables for Pharmaceutical Products 2010 : 14-15 September, 2010, London.
Impurities originating from any part of the manufacturing or storage of drug products can potentially result in expensive product recalls and damage to a company's reputation - not to mention the serious threat posed to patient safety. Nowadays extractables and leachables assessment of all mate...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Shrewsbury :
ISmithers Rapra Pub.,
2010.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Mi 4500 | ||
|---|---|---|---|
| 001 | EBSCO_ocn767502649 | ||
| 003 | OCoLC | ||
| 005 | 20231017213018.0 | ||
| 006 | m o d | ||
| 007 | cr |n|---||||| | ||
| 008 | 111205s2010 xx o 000 0 eng d | ||
| 040 | |a EBLCP |b eng |e pn |c EBLCP |d OCLCQ |d N$T |d OCLCQ |d OCLCO |d YDXCP |d OCLCQ |d ZCU |d MERUC |d IGB |d AGLDB |d D6H |d OCLCQ |d CN8ML |d OCLCQ |d OCLCF |d OCLCQ |d VTS |d OCLCA |d OCLCQ |d S9I |d STF |d M8D |d AJS |d OCLCO |d OCLCQ | ||
| 020 | |a 9781847356123 |q (electronic bk.) | ||
| 020 | |a 1847356125 |q (electronic bk.) | ||
| 029 | 1 | |a DEBBG |b BV044062135 | |
| 035 | |a (OCoLC)767502649 | ||
| 050 | 4 | |a RS200 .E98 2010 | |
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 082 | 0 | 4 | |a 615.4 |
| 049 | |a UAMI | ||
| 100 | 1 | |a Rapra, iSmithers. | |
| 245 | 1 | 0 | |a Extractables & Leachables for Pharmaceutical Products 2010 : |b 14-15 September, 2010, London. |
| 260 | |a Shrewsbury : |b ISmithers Rapra Pub., |c 2010. | ||
| 300 | |a 1 online resource (196 pages) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a data file |2 rda | ||
| 505 | 0 | |a First four pages Extractable; Paper 01 -- Forrest; Paper 02 -- Hawkins; Paper 03 -- Nicholas; Paper 04 -- Worsoe; Paper 05 -- Markovic; Paper 06 -- Egert; Papers 7-11 -- Multi Authors; Paper 12 -- Hodgson; Paper 13 -- Martin; Paper 14 -- Stults; Paper 15 -- Feilden; Paper 16 -- Creasey; Paper 17 -- Senholt; Paper 18 -- Jenke; Paper 19 -- Toynbee; Paper 20 -- Claessens; Paper 21 -- Janssen; Paper 22 -- Wong. | |
| 520 | |a Impurities originating from any part of the manufacturing or storage of drug products can potentially result in expensive product recalls and damage to a company's reputation - not to mention the serious threat posed to patient safety. Nowadays extractables and leachables assessment of all materials - and especially elastomeric and plastic components - forms an integral part of the submission for approval of a new drug system or medical device. With regulatory authorities such as the FDA and the MHRA demanding assurance that a product's integrity has been scrutinised - the pharmaceutical indus. | ||
| 588 | 0 | |a Print version record. | |
| 590 | |a eBooks on EBSCOhost |b EBSCO eBook Subscription Academic Collection - Worldwide | ||
| 650 | 0 | |a Drugs |x Dosage forms |v Congresses. | |
| 650 | 0 | |a Leachate |x Health aspects |v Congresses. | |
| 650 | 0 | |a Drug stability |v Congresses. | |
| 650 | 0 | |a Drug delivery systems |x Safety measures |v Congresses. | |
| 650 | 0 | |a Pharmaceutical technology |x Quality control |v Congresses. | |
| 650 | 0 | |a Pharmaceutical industry |x Quality control |v Congresses. | |
| 650 | 0 | |a Pharmaceutical policy |v Congresses. | |
| 650 | 6 | |a Médicaments |x Formes pharmaceutiques |v Congrès. | |
| 650 | 6 | |a Médicaments |x Stabilité |v Congrès. | |
| 650 | 6 | |a Systèmes d'administration de médicaments |x Sécurité |x Mesures |v Congrès. | |
| 650 | 6 | |a Techniques pharmaceutiques |x Qualité |x Contrôle |v Congrès. | |
| 650 | 6 | |a Industrie pharmaceutique |x Qualité |x Contrôle |v Congrès. | |
| 650 | 6 | |a Médicaments |x Politique gouvernementale |v Congrès. | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Drug stability. |2 fast |0 (OCoLC)fst00898707 | |
| 650 | 7 | |a Drugs |x Dosage forms. |2 fast |0 (OCoLC)fst00898801 | |
| 650 | 7 | |a Pharmaceutical industry |x Quality control. |2 fast |0 (OCoLC)fst01060169 | |
| 650 | 7 | |a Pharmaceutical policy. |2 fast |0 (OCoLC)fst01060194 | |
| 650 | 7 | |a Pharmaceutical technology |x Quality control. |2 fast |0 (OCoLC)fst01060215 | |
| 655 | 7 | |a Conference papers and proceedings. |2 fast |0 (OCoLC)fst01423772 | |
| 776 | 0 | 8 | |i Print version: |a Rapra, iSmithers. |t Extractables & Leachables for Pharmaceutical Products 2010 : 14-15 September, 2010, London. |d Shrewsbury : iSmithers Rapra Publishing, ©2010 |z 9781847355539 |
| 856 | 4 | 0 | |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=653197 |z Texto completo |
| 938 | |a EBSCOhost |b EBSC |n 653197 | ||
| 938 | |a YBP Library Services |b YANK |n 7269356 | ||
| 994 | |a 92 |b IZTAP | ||